Redhill Biopharma
RDHL
#11160
Rank
$2.49 M
Marketcap
$0.28
Share price
-13.08%
Change (1 day)
-72.98%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -$700.00

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -$700.00. In 2017 the company made an earnings per share (EPS) of -$2,500 a decrease over its 2016 EPS that were of -$2,200.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$700.00
2017-$2,50013.64%
2016-$2,2009.12%
2015-$2,01668.01%
2014-$1,200-25.93%
2013-$1,620

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
$1.98-100.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$0.99-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$2.88-100.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$0.45-100.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
$1.22-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel